| abstract |
The invention relates to a trispecific antigen-binding polypeptide dimer comprising a first polypeptide and a second polypeptide, each polypeptide having at least four domains of immunoglobulin chain variable regions linked one after another, wherein two of said four antigen binding sites are specific for the same antigen and the polypeptide can be used as a medicament for tumor therapy. |